29 April - 5 May 2017
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
MS in America
A survey of more than five thousand people with MS in the USA found the most common symptoms reported were fatigue (87%), numbness/tingling (75%), memory loss/brain fog (70%), muscle weakness (64%) and pain (55%). Almost half had had more than five visits to doctors before being diagnosed with MS, and 42% were originally diagnosed with something else. Two thirds started treatment within three months of diagnosis.
Source: MS News Today
MS Trust link: Neurological services in the UK report (news item)
Analysis of stem cell studies
An analysis of 15 previously published studies (using a variety of approaches) found that stem cell therapy (HSCT) stopped progression over two years in 83%. People with relapsing remitting MS did better than those with progressive MS. In the studies since 2005, there had only been one death out of 349 participants.
Source: National MS Society (USA)
MS Trust link: Stem cells therapy